Silverarc Capital Management

Silverarc Capital Management as of March 31, 2022

Portfolio Holdings for Silverarc Capital Management

Silverarc Capital Management holds 68 positions in its portfolio as reported in the March 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr Ser Tr S&p Biotech Call Option (XBI) 11.2 $27M 300k 89.88
Athira Pharma (ATHA) 11.2 $27M 10k 2696.40
Intra Cellular Therapies (ITCI) 7.8 $19M 309k 61.19
Sierra Oncology Com New 5.9 $14M 443k 32.05
Veracyte (VCYT) 4.9 $12M 426k 27.57
Cti Biopharma 4.3 $11M 2.3M 4.67
Merus N V (MRUS) 3.6 $8.6M 325k 26.44
Cerus Corporation (CERS) 3.2 $7.7M 1.4M 5.49
Horizon Therapeutics Pub L SHS 2.9 $7.1M 67k 105.22
Apollo Endosurgery 2.5 $6.1M 1.0M 6.05
Apellis Pharmaceuticals (APLS) 2.2 $5.4M 105k 50.81
Aclaris Therapeutics (ACRS) 2.0 $4.7M 275k 17.24
ImmunoGen Call Option 1.9 $4.5M 945k 4.76
Iteos Therapeutics (ITOS) 1.8 $4.5M 139k 32.18
Biohaven Pharmaceutical Holding 1.8 $4.4M 103k 42.53
Cogent Biosciences (COGT) 1.8 $4.3M 574k 7.49
Mirati Therapeutics 1.6 $3.8M 46k 82.22
Immatics SHS (IMTX) 1.5 $3.6M 445k 7.99
Krystal Biotech (KRYS) 1.3 $3.1M 47k 66.53
Ngm Biopharmaceuticals 1.3 $3.1M 201k 15.25
Otonomy 1.2 $2.9M 1.2M 2.40
Morphic Hldg (MORF) 1.1 $2.8M 69k 40.15
United Therapeutics Corporation (UTHR) 1.1 $2.7M 15k 179.43
Galapagos Nv Spon Adr (GLPG) 1.1 $2.5M 41k 62.02
Crinetics Pharmaceuticals In (CRNX) 1.0 $2.5M 114k 21.95
Insmed Com Par $.01 (INSM) 1.0 $2.4M 102k 23.50
Miragen Therapeutics (VRDN) 1.0 $2.3M 126k 18.49
Seres Therapeutics (MCRB) 1.0 $2.3M 327k 7.12
Eyepoint Pharmaceuticals Com New (EYPT) 0.9 $2.3M 186k 12.15
Vertex Pharmaceuticals Incorporated (VRTX) 0.8 $2.0M 7.6k 260.93
Neurocrine Biosciences (NBIX) 0.8 $1.9M 21k 93.74
Leap Therapeutics 0.7 $1.8M 1.0M 1.75
Syndax Pharmaceuticals (SNDX) 0.7 $1.8M 101k 17.38
Viewray (VRAYQ) 0.7 $1.7M 436k 3.92
Jounce Therapeutics 0.7 $1.7M 248k 6.79
Codexis (CDXS) 0.7 $1.7M 81k 20.62
Point Biopharma Global 0.7 $1.6M 205k 7.97
Forma Therapeutics Hldgs SHS 0.7 $1.6M 175k 9.30
Iveric Bio Put Option 0.7 $1.6M 95k 16.83
Aslan Pharmaceuticals Ads 0.7 $1.6M 500k 3.18
Seagen 0.7 $1.6M 11k 144.03
Xenon Pharmaceuticals (XENE) 0.6 $1.4M 101k 14.13
Ascendis Pharma A/s Sponsored Adr (ASND) 0.6 $1.4M 25k 57.12
Cyclacel Pharmaceuticals 0.6 $1.4M 463k 3.05
Stereotaxis Com New (STXS) 0.5 $1.3M 346k 3.73
Medicus Sciences Acquisition Cl A Shs 0.5 $1.3M 131k 9.78
Amryt Pharma Sponsored Ads 0.5 $1.3M 153k 8.27
Polypid SHS 0.5 $1.2M 218k 5.46
Lucira Health 0.5 $1.1M 311k 3.57
Eloxx Pharmaceuticals 0.5 $1.1M 2.0M 0.56
Poseida Therapeutics I (PSTX) 0.4 $1.1M 240k 4.48
Nextcure (NXTC) 0.4 $953k 196k 4.86
Compugen Ord (CGEN) 0.4 $865k 269k 3.22
Immunic (IMUX) 0.3 $774k 69k 11.30
Eliem Therapeutics (ELYM) 0.3 $741k 88k 8.39
Aptinyx Put Option 0.2 $458k 202k 2.27
Amylyx Pharmaceuticals (AMLX) 0.2 $386k 30k 12.87
Evogene SHS (EVGN) 0.2 $384k 296k 1.30
Mereo Biopharma Group Ads (MREO) 0.1 $264k 236k 1.12
Celldex Therapeutics Com New (CLDX) 0.1 $256k 46k 5.62
Biogen Idec (BIIB) 0.1 $230k 10k 22.44
BioCryst Pharmaceuticals (BCRX) 0.1 $197k 102k 1.92
Bellus Health Com New 0.1 $177k 1.2M 0.14
Calithera Biosciences 0.0 $74k 222k 0.33
Benitec Biopharma 0.0 $57k 493k 0.12
Renovacor *w Exp 99/99/999 0.0 $33k 105k 0.31
Aligos Therapeutics (ALGS) 0.0 $23k 11k 2.16
Medicus Sciences Acquisition *w Exp 02/12/202 0.0 $21k 50k 0.42